高级检索
    王树森, 孙业桓. PALOMA-3研究分析: 氟维司群联合Palbociclib显著提高内分泌治疗进展的晚期乳腺癌的无进展生存期[J]. 循证医学, 2016, 16(3): 152-154. DOI: 10.12019/j.issn.1671-5144.2016.03.009
    引用本文: 王树森, 孙业桓. PALOMA-3研究分析: 氟维司群联合Palbociclib显著提高内分泌治疗进展的晚期乳腺癌的无进展生存期[J]. 循证医学, 2016, 16(3): 152-154. DOI: 10.12019/j.issn.1671-5144.2016.03.009
    shu
    Reviewer: WANG Shu-sen, Literature Co-worker: ZHANG Liu-lu. PALOMA-3 Trial: Fulvestrant Plus Palbociclib Improve Progression-Free Survival of Advanced Breast Cancer Patients with Endocrine Treatment Failure[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 152-154. DOI: 10.12019/j.issn.1671-5144.2016.03.009
    Citation: Reviewer: WANG Shu-sen, Literature Co-worker: ZHANG Liu-lu. PALOMA-3 Trial: Fulvestrant Plus Palbociclib Improve Progression-Free Survival of Advanced Breast Cancer Patients with Endocrine Treatment Failure[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 152-154. DOI: 10.12019/j.issn.1671-5144.2016.03.009
    shu

    PALOMA-3研究分析: 氟维司群联合Palbociclib显著提高内分泌治疗进展的晚期乳腺癌的无进展生存期

    PALOMA-3 Trial: Fulvestrant Plus Palbociclib Improve Progression-Free Survival of Advanced Breast Cancer Patients with Endocrine Treatment Failure

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回